11
Dec
Dr. Thomas Frischmuth at JP Morgan Health 2026 Conference
We are pleased to announce that Dr. Thomas Frischmuth will attending the JP Morgan Health 2026 Conference to present integrated oligonucleotide drug delivery solutions. Our
MORE →-
-
28
Octbaseclick is joining BIO-Europe 2025 in Vienna, Driving Partnerships
Nazifa Hamidzada (Head of Business Development – Marketing & Sales) and Dr. Thomas Frischmuth (CEO) will attend BIO‑Europe 2025 in Vienna, November 3–5 for partnering
MORE → -
16
Octbaseclick accelerates innovation in growing Click Chemistry Market
Neuried, Germany (October 16, 2025) The global Click Chemistry and Bioorthogonal Chemistry Market is projected to experience strong growth, according to the latest report from
MORE → -
23
Julbaseclick is joining INT2ACT project to advance nucleic acid technologies
The INT2ACT (Innovative Nucleic Acids Technologies for Analysis, Detection and Treatment) consortium has been awarded funding under the prestigious Marie Skłodowska-Curie Actions (MSCA) program by
MORE → -
18
JulEnhancing Fibrotic Lung Research: How baseclick’s Sugar-Ligand Technology Advances Drug Targeting
Pulmonary fibrosis remains one of the most challenging and poorly treatable chronic diseases. Despite promising in vitro findings, many anti-fibrotic compounds fail in clinical translation
MORE →